Apnimed, Inc. (APMD)
NASDAQ: APMD · Real-Time Price · USD
28.08
-0.71 (-2.47%)
Sep 9, 2026, 4:00 PM EDT - Market closed
Apnimed Revenue
Apnimed had revenue of $84.81M in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $120.15M. In the year 2025, Apnimed had annual revenue of $38.47M with 380.12% growth.
Revenue (ttm)
$120.15M
Revenue Growth
+380.12%
P/S Ratio
12.95
Revenue / Employee
$1,848,462
Employees
65
Market Cap
1.56B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 38.47M | 30.46M | 380.12% |
| Dec 31, 2024 | 8.01M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 1.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
APMD News
- 1 day ago - Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 days ago - Apnimed Quarterly report: Q2 2026 - Filings
- 2 days ago - Apnimed Earnings release: Q2 2026 - Filings
- 5 days ago - Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 16 days ago - Apnimed initiated with an Overweight at Cantor Fitzgerald - TheFly
- 16 days ago - Apnimed initiated with an Overweight at Cantor Fitzgerald - TheFly
- 16 days ago - Apnimed initiated with an Outperform at Evercore ISI - TheFly
- 16 days ago - Apnimed initiated with an Outperform at LifeSci Capital - TheFly